Urotronic, Inc.

2495 Xenium Ln N, Minneapolis, Minnesota, United States

Also known as:

medical device

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

60.0%

Early Phase 1

10.0%

Phase 2

10.0%

Phase 4

10.0%

Trial Status Distribution

Active, not recruiting

30.0%

Completed

30.0%

Recruiting

30.0%

Withdrawn

10.0%

Clinical Trials

Trials sponsored by this organization (10)

EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures

Not Applicable

Recruiting

interventional

Oct 202560 participants

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

Active, not recruiting

observational

Mar 2024500 participants

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

Not Applicable

Recruiting

interventional

Feb 202492 participants

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

Phase 4

Recruiting

interventional

Feb 202234 participants

Optilume™ BPH Catheter System in Men With Symptomatic BPH

Not Applicable

Active, not recruiting

interventional

Feb 2020162 participants

Re-Establishing Flow Via Drug Coated Balloon for the Treatment of Urethral Stricture Disease - Registry Study

ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease

Not Applicable

Active, not recruiting

interventional

Jun 2018127 participants

Optilume™ BPH Prostatic Drug Coated Balloon Dilation Catheter

Phase 2

Completed

interventional

Dec 201780 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations